PMR Online access    |   tel. +48 12 618 90 00    |   E-mail: info@pmrcorporate.com
 
Ministry unveils new reimbursement lists 2013-08-20
The Health Ministry on 19 August published for consultation a draft update of the reimbursement lists, due to take effect on 1 September. Under the proposal, 23 new products (EAN codes) are to be added to the pharmacy ... more »
Inno-Gene posts dynamic sales growth in Q2 as new ventures prepare to start operations 2013-08-21
Inno-Gene, the start-up genetics and biotech group, expects its newly created subsidiaries Genomix, which will develop diagnostic products for the ... more »
Ministry outlines changes to Reimbursement Act 2013-08-07
After months of consultation, the Health Ministry on 1 August unveiled a draft proposal of changes to the Reimbursement Act. The objective is to ... more »

see more news »

Dr. Max expected to lead Polish pharmacy market
Dr. Max, which was is owned by Penta Investments, was the largest independent pharmacy chain in Poland (not owned by a wholesaler) even before the acquisition of Mediq, and the acquisition of the latter would make it ... more »

PMR Insight: Companies compete to develop biosimilar of Roche’s MabThera  Click and register to open this news 2013-08-21
Roche (along with Genentech, a Roche subsidiary) has protection from competition for Mabthera and Rituxan (rituximab – a monoclonal antibody which targets CD20, used to treat B cell malignancies and B cell-mediated ... more »
more »
Upcoming events
The most relevant trades, fairs & conferences worldwide from your sector of interest.
  • chronological list with all the necessary information
  • events connected with doing busines in CEE - all in one place
  • careful selection from your area of interest
  • events taking place locally and across the world
  • discounts for PMR clients - save on participation fee!
See the list of events »

Free e-letter with overview of news, analyses and reports from the pharmaceutical and healthcare sector in Poland, Russia and CEE.


Oncological pharmaceuticals and immunosuppressive drugs were the driving force pushing the growth of the pharmaceutical market in 2008-2009. The ... more »

W latach 2008-2009 r. leki onkologiczne i immunomodulujące były motorem wzrostu rynku leków. Główną tego przyczyną była zmiana statusu ... more »

The years 2013-2014 will be affected by the implications of the Reimbursement Act too, though the impact will be less severe than ... more »
see more free articles »
 
Newsletter covering the pharmaceutical sector in Poland and containing news and analyses.


more »


Research & consulting services

PMR is a market research and consulting company active within over 25 countries of Central and Eastern Europe. Since 1995 we have been working for more than 500 global corporations, as well as for many regional companies.

Each year we run around 200 custom projects for our clients assisting them to continuously increase their market share, successfully enter new territories and optimise costs.

PMR consultants, analysts and researchers create premium value for companies that need:

Request a proposal tailored for your company!

 

Useful links         Privacy Policy
Copyright © 2014 PMR. All rights reserved.

PMR is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.